Cormorant Asset Management as of March 31, 2021
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 119 positions in its portfolio as reported in the March 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ishares Tr Russell 2000 Etf Put Option (IWM) | 9.8 | $442M | 2.0M | 220.94 | |
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 8.8 | $396M | 1.0M | 396.33 | |
Atea Pharmaceuticals (AVIR) | 8.8 | $396M | 6.4M | 61.75 | |
Turning Point Therapeutics I | 5.8 | $260M | 2.8M | 94.59 | |
Design Therapeutics (DSGN) | 3.3 | $146M | 5.1M | 28.62 | |
Spdr Ser Tr S&p Biotech Put Option (XBI) | 3.0 | $136M | 1.0M | 135.65 | |
Bridgebio Pharma (BBIO) | 3.0 | $134M | 2.2M | 61.60 | |
Forma Therapeutics Hldgs SHS | 2.9 | $132M | 4.7M | 28.02 | |
Revolution Medicines (RVMD) | 2.6 | $116M | 2.5M | 45.88 | |
Bioatla (BCAB) | 2.4 | $110M | 2.2M | 50.15 | |
Olema Pharmaceuticals (OLMA) | 2.3 | $105M | 3.2M | 32.88 | |
C4 Therapeutics Com Stk (CCCC) | 2.1 | $92M | 2.5M | 36.99 | |
Apellis Pharmaceuticals (APLS) | 1.8 | $80M | 1.9M | 42.91 | |
Omeros Corporation (OMER) | 1.7 | $77M | 4.3M | 17.80 | |
Edgewise Therapeutics (EWTX) | 1.7 | $74M | 2.3M | 31.74 | |
Alx Oncology Hldgs (ALXO) | 1.4 | $65M | 882k | 73.74 | |
Zymeworks | 1.4 | $63M | 2.0M | 31.58 | |
Rocket Pharmaceuticals (RCKT) | 1.4 | $61M | 1.4M | 44.37 | |
Stoke Therapeutics (STOK) | 1.2 | $56M | 1.4M | 38.84 | |
Tarsus Pharmaceuticals (TARS) | 1.2 | $55M | 1.7M | 32.23 | |
Avidity Biosciences Ord (RNA) | 1.2 | $54M | 2.5M | 21.81 | |
Aclaris Therapeutics (ACRS) | 1.1 | $50M | 2.0M | 25.20 | |
Mirati Therapeutics | 1.0 | $47M | 275k | 171.30 | |
Novavax Com New (NVAX) | 1.0 | $45M | 250k | 181.31 | |
Chemocentryx | 1.0 | $44M | 850k | 51.24 | |
Axonics Modulation Technolog (AXNX) | 0.9 | $42M | 693k | 59.89 | |
Dermtech Ord ord (DMTK) | 0.9 | $41M | 800k | 50.79 | |
Reata Pharmaceuticals Cl A | 0.9 | $40M | 400k | 99.70 | |
Igm Biosciences (IGMS) | 0.8 | $38M | 496k | 76.69 | |
Acceleron Pharma | 0.8 | $37M | 275k | 135.61 | |
Y Mabs Therapeutics (YMAB) | 0.8 | $37M | 1.2M | 30.24 | |
Longboard Pharmaceuticals In (LBPH) | 0.8 | $37M | 2.4M | 15.79 | |
Prometheus Biosciences | 0.8 | $37M | 2.1M | 17.46 | |
Praxis Precision Medicines I | 0.8 | $35M | 1.1M | 32.76 | |
Female Health (VERU) | 0.7 | $32M | 3.0M | 10.78 | |
Aligos Therapeutics (ALGS) | 0.6 | $29M | 1.3M | 22.74 | |
908 Devices (MASS) | 0.6 | $26M | 545k | 47.53 | |
Intellia Therapeutics Put Option (NTLA) | 0.5 | $24M | 300k | 80.25 | |
Pliant Therapeutics (PLRX) | 0.5 | $24M | 611k | 39.33 | |
Blueprint Medicines (BPMC) | 0.5 | $24M | 247k | 97.23 | |
Aptose Biosciences Com New | 0.5 | $24M | 4.0M | 5.97 | |
Pharvaris N V (PHVS) | 0.5 | $24M | 864k | 27.55 | |
Twist Bioscience Corp (TWST) | 0.5 | $23M | 185k | 123.86 | |
Sorrento Therapeutics Com New (SRNEQ) | 0.5 | $23M | 2.8M | 8.27 | |
Morphic Hldg (MORF) | 0.5 | $22M | 350k | 63.28 | |
Silverback Therapeutics (SPRY) | 0.5 | $22M | 500k | 43.63 | |
Akero Therapeutics (AKRO) | 0.5 | $22M | 743k | 29.01 | |
Cabaletta Bio (CABA) | 0.5 | $21M | 1.9M | 11.10 | |
Agenus Com New (AGEN) | 0.5 | $21M | 7.8M | 2.72 | |
Myovant Sciences | 0.5 | $21M | 1.0M | 20.58 | |
Zai Lab Adr (ZLAB) | 0.4 | $20M | 150k | 133.43 | |
Tcr2 Therapeutics Inc cs | 0.4 | $20M | 900k | 22.08 | |
Kalvista Pharmaceuticals (KALV) | 0.4 | $19M | 750k | 25.69 | |
Humanigen Com New (HGENQ) | 0.4 | $19M | 1.0M | 19.10 | |
Connect Biopharma Hldgs Ads (CNTB) | 0.4 | $19M | 1.0M | 18.50 | |
Albireo Pharma | 0.4 | $18M | 500k | 35.25 | |
Inspire Med Sys (INSP) | 0.4 | $18M | 85k | 206.99 | |
Eledon Pharmaceuticals (ELDN) | 0.3 | $15M | 1.4M | 10.70 | |
Repare Therapeutics Ord (RPTX) | 0.3 | $14M | 462k | 30.69 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $14M | 650k | 21.55 | |
Beam Therapeutics (BEAM) | 0.3 | $14M | 172k | 80.04 | |
Biohaven Pharmaceutical Holding | 0.3 | $14M | 200k | 68.35 | |
Foghorn Therapeutics (FHTX) | 0.3 | $13M | 1.0M | 13.18 | |
Galecto (GLTO) | 0.3 | $13M | 2.2M | 6.08 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.3 | $13M | 100k | 128.88 | |
Harpoon Therapeutics | 0.3 | $12M | 571k | 20.92 | |
Axsome Therapeutics (AXSM) | 0.3 | $11M | 200k | 56.62 | |
Theravance Biopharma (TBPH) | 0.3 | $11M | 550k | 20.41 | |
Aveo Pharmaceuticals Com New | 0.2 | $11M | 1.5M | 7.32 | |
Biontech Se Sponsored Ads (BNTX) | 0.2 | $11M | 100k | 109.19 | |
Iteos Therapeutics (ITOS) | 0.2 | $10M | 300k | 34.18 | |
Insmed Com Par $.01 (INSM) | 0.2 | $10M | 300k | 34.06 | |
Springworks Therapeutics (SWTX) | 0.2 | $9.2M | 125k | 73.57 | |
Health Sciences Acq Corp 2 Ord Shs | 0.2 | $9.0M | 800k | 11.23 | |
Deciphera Pharmaceuticals (DCPH) | 0.2 | $9.0M | 200k | 44.84 | |
Bctg Acquisition Corp | 0.2 | $8.9M | 800k | 11.12 | |
4d Molecular Therapeutics In (FDMT) | 0.2 | $8.7M | 200k | 43.38 | |
Uniqure Nv SHS (QURE) | 0.2 | $8.4M | 250k | 33.69 | |
Argenx Se Sponsored Adr (ARGX) | 0.2 | $8.3M | 30k | 275.40 | |
Gossamer Bio (GOSS) | 0.2 | $7.8M | 848k | 9.25 | |
Miragen Therapeutics (VRDN) | 0.2 | $7.7M | 459k | 16.71 | |
Merus N V (MRUS) | 0.2 | $7.3M | 350k | 20.89 | |
Magenta Therapeutics | 0.2 | $7.1M | 600k | 11.84 | |
Akouos | 0.2 | $6.9M | 500k | 13.87 | |
Genetron Hldgs Ads | 0.1 | $6.4M | 300k | 21.46 | |
Gemini Therapeutics | 0.1 | $6.4M | 475k | 13.55 | |
Cullinan Oncology (CGEM) | 0.1 | $6.3M | 150k | 41.67 | |
Quotient SHS | 0.1 | $5.5M | 1.5M | 3.68 | |
Protara Therapeutics Com Stk (TARA) | 0.1 | $5.5M | 350k | 15.74 | |
Immunovant (IMVT) | 0.1 | $5.4M | 337k | 16.04 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $5.3M | 500k | 10.57 | |
Therapeutics Acquisition Cor Com Cl A | 0.1 | $5.3M | 500k | 10.51 | |
Sarepta Therapeutics (SRPT) | 0.1 | $5.2M | 70k | 74.53 | |
5 01 Acquisition Corp Com Cl A | 0.1 | $5.0M | 500k | 9.98 | |
Vesper Healthcare Acqstn Cor Unit 99/99/9999 | 0.1 | $4.6M | 400k | 11.55 | |
Atreca Cl A Com (BCEL) | 0.1 | $4.5M | 294k | 15.33 | |
Helix Acquisition Corp Com Cl A | 0.1 | $4.4M | 430k | 10.20 | |
Replimune Group (REPL) | 0.1 | $3.8M | 125k | 30.51 | |
Instil Bio | 0.1 | $3.8M | 150k | 25.08 | |
Precision Biosciences Ord | 0.1 | $3.6M | 347k | 10.35 | |
Eiger Biopharmaceuticals | 0.1 | $3.5M | 400k | 8.85 | |
Kadmon Hldgs | 0.1 | $2.9M | 750k | 3.89 | |
Allakos (ALLK) | 0.1 | $2.9M | 25k | 114.80 | |
Nuvation Bio Com Cl A (NUVB) | 0.1 | $2.4M | 234k | 10.45 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $2.4M | 422k | 5.73 | |
Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.1 | $2.4M | 130k | 18.51 | |
Tricida | 0.1 | $2.3M | 428k | 5.29 | |
Gracell Biotechnologies Sponsored Ads | 0.0 | $1.9M | 125k | 15.40 | |
Orchard Therapeutics Ads | 0.0 | $1.9M | 257k | 7.26 | |
Cardiff Oncology (CRDF) | 0.0 | $1.4M | 150k | 9.26 | |
Arena Pharmaceuticals Com New | 0.0 | $1.4M | 20k | 69.40 | |
X4 Pharmaceuticals (XFOR) | 0.0 | $895k | 104k | 8.61 | |
Fate Therapeutics (FATE) | 0.0 | $824k | 10k | 82.40 | |
Imv | 0.0 | $772k | 234k | 3.29 | |
Minerva Neurosciences | 0.0 | $584k | 200k | 2.92 | |
Cerevel Therapeutics Hldng I *w Exp 06/09/202 (CEREW) | 0.0 | $563k | 133k | 4.22 | |
Outlook Therapeutics *w Exp 02/18/202 | 0.0 | $421k | 417k | 1.01 | |
Nektar Therapeutics (NKTR) | 0.0 | $400k | 20k | 20.00 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $222k | 83k | 2.66 |